

See product citations (12)
QUICK LINKS
FK-866 may act to induce apoptosis by non-competitive, and specific inhibition of PBEF (nicotamide phosphoribosyltransferase, NAMPT). PBEF (NAMPT) is a key regulatory enzyme that mediates NAD+ biosynthesis within cells. Mechanistic studies show that this compound contains an enzymatic active site of visfatin which is optimized for nicotinamide binding and inhibition. Visfatin also contains a similar structure to insulin and mimics its actions by binding to the insulin receptors.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
FK-866, 5 mg | sc-205325 | 5 mg | $143.00 | |||
FK-866, 10 mg | sc-205325A | 10 mg | $250.00 |